To determine any beneficial effect by PIK-75-mediated downregulation of NRF2 in pancreatic cancer cells to cytotoxicity of gemcitabine, the effect of PIK-75/gemcitabine combination on the proliferation of pancreatic cancer cells was performed by MTT cell viability assay. The gene discussed is NFE2L2; the disease is familial pancreatic carcinoma.